| abstract |
SGLTs protein inhibitor, preparation method the present invention relates to one kind with formula (I) structure and application pharmaceutically.Series compound of the present invention can be widely applied to treatment diabetes, diabetic retinopathy, diabetic neuropathy, nephrosis, insulin resistance, hyperglycemia, hyperinsulinemia, raised level, hyperlipidemia, obesity, hypertriglyceridemia, X syndrome, diabetic complication or the diseases such as atherosclerosis or hypertension of fatty acid or glycerol, be expected to exploitation into sodium dependent glucose transport protein (SGLTs) inhibitor of new generation. |